Arverne Announces Initiation of Coverage on Its Stock by Portzamparc
Target price of €10.60, representing an upside potential of 18%
PAU, France--(BUSINESS WIRE)-- Regulatory News:
Arverne (FR001400JWR8 - ARVEN), France's leading provider of geothermal solutions, announces the initiation of coverage on its stock by Portzamparc BNP Paribas Group.
In his report entitled “Arverne, a Leader in Energy Sovereignty and Transition”, published on June 22, 2026, Nicolas Delmas initiates coverage of Arverne with a Buy recommendation and a 12-month target price of €10.60 per share, representing an upside potential of 18% compared to the closing price on June 19, 2026.
This initiation of coverage will enhance the Group’s visibility within the financial community by providing an in-depth analysis of its strategic positioning, business model, and growth drivers.
It complements existing analyst coverage and contributes to enriching market consensus, alongside TP ICAP, ODDO BHF, Kepler Chevreux and CIC Market Solutions.
Next Event: September 23, 2026, H1 2026 results
About Arverne
ARVERNE is the leading French supplier of geothermal solutions.
It specialises in harnessing natural ground resources to transform them into local energy sources for heating and cooling systems and to extract lithium. A mission-driven company listed on Euronext Paris, Arverne works for local authorities and industrial companies with a focus on energy sovereignty and short supply chains.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260622173356/en/
Media Relations: Enora Budet [email protected] - +33672178460
Investor Relations: Mathilde Guillemot [email protected]
Source: ARVERNE GROUP
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Resecurity and the National Cybercrime Unit of the National Police of Ecuador (CiberPOL) Signed a Memorandum of Understanding (MoU) to Strengthen the Prevention and Investigation of Cybercrimes
- European Commission Approves DAYBU® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union
- Share buybacks in Ericsson during the period August 17 - August 21, 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share